Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.
Scholarly article — Clinical Trial, Phase II / Journal Article / Multicenter Study / Research Support, Non-U.S. Gov't
Study designOther literature / records
SubjectHuman
Record checks
- Study design
- Other literature / records
- Subject
- Human
- Publication year
- 2020
- Source
- doi.org
- Abstract display
- Not reproduced here
- Publication status
- Active
- Status checked
- 17 Aug 2026
- Collected
- 13 Aug 2026
- Freshness
- Current
- Review stage
- Automated
- Record status
- Published
Abstract
The abstract is not reproduced here. Please consult the original source.
MeSH
DOI 10.1016/j.cllc.2020.07.012
PMID 32859536
View source →